US Patent 8809051 Transgenic mammals having human Ig loci including plural V
Patent 8809051 was granted and assigned to Amgen on August, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Aya Jakobovits0
Larry Green0
Michael J Mendez0
Raju Kucherlapati0
Susan Klapholz0
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08809051 Transgenic mammals having human Ig loci including plural V US Patent 8809051 Transgenic mammals having human Ig loci including plural V
Infobox
Patent Number
088090510
Patent Number
88090510
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
088090510
Date of Patent
August 19, 2014
0Patent Application Number
118947790
Date Filed
August 20, 2007
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 24 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08809051 Transgenic mammals having human Ig loci including plural V
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08809051
Date of patent
August 19, 2014
Patent application number
11894779
Date Filed
August 20, 2007
Patent primary examiner
Find more entities like US Patent 8809051 Transgenic mammals having human Ig loci including plural V
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
